Assessment of serum CD5L as a biomarker to distinguish etiology and predict mortality in adults with pneumonia. Chen T, Duan J, Li M, Wu X, et al. J Infect 2020;80:469-496.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen T, Duan J, Li M, Wu X, et al. Assessment of serum CD5L as a biomarker to distinguish etiology and predict mortality in adults with pneumonia. J Infect 2020;80:469-496.
PMID: 31837340